http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-035174-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ef8acc27b4252e343aa5da877c870d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2001-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5891c938ba284649da1922a6585db0ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5f43c0baee0c75604c4e122b5c132d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5df84b24019173462d29357c5eed9fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45e6f18ea6c3ccf556dc09bc4c3205ec |
| publicationDate | 2004-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-035174-A1 |
| titleOfInvention | COMPOSITE DERIVED FROM BETA-AMINOACIDO, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE IN THE MANUFACTURE OF MEDICINES TO TREAT OR PREVENT INFLAMMATORY DISORDERS AND DISEASES MEDIATED BY MMP, TNF AND AGRECANSA AND COMBINATIONS OF THE SAME |
| abstract | Compound derived from b-amino acid of the formula (1), or a stereoisomer or a salt form acceptable for pharmaceutical use thereof, wherein: A is selected from -COR5, -CO2H, -CO2R6, -C (O) NHOH, -C (O) NHOR5, -C (O) NHOR6, -NHRa, -N (OH) COR5, -C (OH) CHO, -SH, -CH2SH, -S (O) (= NH) Ra, -S (= NH) 2Ra, -SC (O) Ra, -PO (OH) 2, and -PO (OH) NHRa; X is absent or selected from C1-3 alkylene, C2-3 alkenylene, and C2-3 alkynylene; Z is absent or selected from a C3-13 carbocycle substituted with 0-5 Rb and a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O and S (O) py is substituted with 0-5 Rb, Ua is absent or is selected from: O, NRa1, C (O), C (O) O, OC (O), C (O) NRa1, NRa1C (O), OC (O ) O, OC (O) NRa1, NRa1C (O) O, NRa1C (O) NRa1, S (O) p, S (O) pNRa1, NRa1S (O) p, and NRa1SO2NRa1; Xa is absent or is selected from C1-10 alkylene, C2-10 alkenylene, and C2-10 alkynylene; It is already absent or is selected from O, NRa1, S (O) p, and C (O); Za is selected from H, a C3-13 carbocycle substituted with 0-5 Rc and a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O, and S (O) py it is substituted with 0-5 Rc; with the proviso that Z, Ua, Ya and Za do not combine to form an N-N, N-O, O-N, O-O, S (O) p-O, O-S (O) p or S (O) p-S (O) p group; R1 is selected from H, C1-4 alkyl, phenyl and benzyl; R2 is selected from Q, alkylene-Q C1-6, alkenylene-Q C2-6, alkynylene-Q C2-6, (CRaRa1) r1O (CRaRa1) rQ, (CRaRa1) r1NRa (CRaRa1) rQ, (CRaRa1) r1C ( O) (CRaRa1) rQ, (CRaRa1) r1C (O) O (CRaRa1) rQ, (CRaRa1) r1OC (O) (CRaRa1) rQ, (CRaRa1) r1C (O) NRaRa1, (CRaRa1) r1C (O) NRa ( CRaRa1) rQ, (CRaRa1) r1NRaC (O) (CRaRa1) rQ, (CRaRa1) r1OC (O) O (CRaRa1) rQ, (CRaRa1) r1OC (O) NRa (CRaRa1) rQ, (CRaRa1) r1NRaC (O) (CRaRa1) rQ, (CRaRa1) r1NRaC (O) NRa (CRaRa1) rQ, (CRaRa1) r1S (O) p (CRaRa1) rQ, (CRaRa1) r1SO2NRa (CRaRa1) rQ, (CRaRa1) r1NQ1, r1NR1, r1Q1 (CRaRa1) r1NRaSO2NRa (CRaRa1) rQ; Q is selected from H, a C3-13 carbocycle substituted with 0-5 Rd and a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O and S (O) p and is replaced with 0-5 Rd; R3 is selected from Q1, alkylene-Q1 C1-6, alkenylene-Q1 C2-6, alkynylene-Q1 C2-6, (CRaRa1) r1O (CH2) r-Q1, (CRaRa1) r1NRa (CRaRa1) r-Q1, ( CRaRa1) r1NRaC (O) (CRaRa1) r-Q1, (CRaRa1) r1C (O) NRa (CRaRa1) r-Q1, (CRaRa1) r1C (O) (CRaRa1) r-Q1, (CRaRa1) r1C (O) O (CRaRa1) r-Q1, (CRaRa1) 2r1S (O) p (CRaRa1) r-Q1, and (CRaRa1) r1SO2NRa (CRaRa1) r-Q1; Q1 is selected from H, a C3-13 carbocycle substituted with 0-5 Rd and a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O and S (O) p and is replaced with 0-5 Rd; R4 is selected from H, C1-6 alkyl substituted with 0-1 Rb; C2-6 alkenyl substituted with 0-1 Rb, and C2-6 alkynyl substituted with 0-1 Rb; R4a is selected from H, C1-6 alkyl substituted with 0-1 Rb, C2-6 alkenyl substituted with 0-1 Rb and C2-6 alkynyl substituted with 0-1 Rb; alternatively, R1 and R2 together with the carbon and nitrogen atoms to which they are attached combine to form a 3 to 10 membered heterocyclic ring comprising carbon atoms and, in addition to the nitrogen atom to which R1 is attached, 0 to 2 ring heteroatoms selected from O, N, NRc and S (O) p and substituted with 0-3 Rc; alternatively, R1 and R3 together with the carbon and nitrogen atoms to which they are attached combine to form a 4- to 6-membered heterocyclic ring comprising carbon atoms and, in addition to the nitrogen atom to which R1 is attached, 0 at 1 ring heteroatoms selected from O, N, NRc, and S (O) p and substituted with 0-1 Rc; alternatively, R3 and R4a together with the carbon atom to which they are attached combine to form a 3 to 10 membered carbocyclic or heterocyclic ring comprising carbon atoms and 0 to 2 ring heteroatoms selected from O, N, NRc, and S (O) py substituted with 0-3 Rc; with the proviso that 0 to 2 between R1 and R2, R1 and R3 and R3 and R4a combine to form a ring; Ra, in each case, is independently selected from H and C1-6 alkyl; Ra1, in each case, is independently selected from H, C1-6 alkyl substituted with 0-1 Rc1, C2-6 alkenyl substituted with 0-1 Rc1, C2-6 alkynyl substituted with 0-1 Rc1, and carbocyclic or heterocyclic ring - (CH2) r- from 3 to 8 members comprising carbon atoms and 0 to 2 ring heteroatoms selected from N, NRc1, O and S (O) p and substituted with 0-3 Rc1; alternatively, Ra and Ra1 when attached to a nitrogen atom are taken together with the nitrogen atom to which they are attached to form a 5- to 6-membered heterocycle comprising carbon atoms and between 0 and 1 additional heteroatoms selected from N , NRa2, O, and S (O) p; Ra2, in each case, is independently selected from C1-4 alkyl, phenyl, and benzyl; Ra3, in each case, is independently selected from H, C1-6 alkyl substituted with 0-1 Rc1, C2-6 alkenyl substituted with 0-1 Rc1, C2-6 alkynyl substituted with 0-1 Rc1, and carbocyclic or heterocyclic ring - (CH2) r- from 3 to 8 members comprising carbon atoms and 0 to 2 ring heteroatoms selected from N, NRc1, O, and S (O) p and substituted with 0-3 Rc1; Rb, in each case, is independently selected from C1-6 alkyl substituted with 0-1 Rc1, ORa, Cl, F, Br, I, = O, -CN, NO2, NRaRa1, C (O) Ra, C (O ) ORa, C (O) NRaRa1, C (S) NRaRa1, NRaC (O) NRaRa1, OC (O) NRaRa1, NRaC (O) ORa, S (O) 2NRaRa1, NRaS (O) 2Ra3, NRaS (O) 2NRaRa1 , OS (O) 2NRaRa1, NRaS (O) 2Ra3, S (O) pRa3, CF3, and CF2CF3; Rc, in each case, is independently selected from H, C1-6 alkyl substituted with 0-2 Rc1, C2-6 alkenyl substituted with 0-2 Rc1, C2-6 alkynyl substituted with 0-2 Rc1; ORa, Cl, F, Br, I, = O, -CN, NO2, (CRaRa1) r1NRaRa1, CF3, CF2CF3, (CRaRa1) r1C (= NCN) NRaRa1, (CRaRa1) r1C (= NRa) NRaRa1, (CRaRa1) r1C (= NORa) NRaRa1, (CRaRa1) r1C (O) NRaOH, (CRaRa1) r1C (O) Ra1, (CRaRa1) r1C (O) ORa1, (CRaRa1) r1C (S) ORa1, (CRaRa1) r1C (O) NRaRa1, (CRaRa1) r1NRaC (O) Ra1, (CRaRa1) r1C (S) NRaRa1, (CRaRa1) r1OC (O) NRaRa1, (CRaRa1) r1NRaC (O) ORa1, (CRaRa1) r1NRaC (CRR) NR1 (CRaR1) r1S (O) pRa3, (CRaRa1) r1SO2NRaRa1, (CRaRa1) r1NRaSO2Ra3, and (CRaRa1) r1NRaSO2NRaRa1, a C3-10 carbocycle substituted with 0-2 Rc1, (CRaRa1) carb-1-R3-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3-R1-C3 , a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O and S (O) py substituted with 0-2 Rc1, and (CRaRa1) r1- 5-14 heterocycle members comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O and S (O) p and substituted with 0-2 Rc1; Rc1, in each case, is independently selected from H, C1-4 alkyl, ORa, Cl, F, Br, I, = O, CF3, -CN, NO2, C (O) ORa, and C (O) NRaRa1; Rd, in each case, is independently selected from C1-6 alkyl, ORa, Cl, F, Br, I, = O, -CN, NO2, NRaRa1, C (O) Ra, C (O) ORa, C (O ) NRaRa1, C (S) NRaRa1, RaNC (O) NRaRa1, OC (O) NRaRa1, RaNC (O) O, S (O) 2NRaRa1, NRaS (O) 2Ra3, NRaS (O) 2NRaRa1, OS (O) 2NRaRa1 , NRaS (O) 2Ra3, S (O) pRa3, CF3, CF2CF3, a C3-10 carbocycle and a 5-14 membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from the group consisting of N, O, and S (O) p; R5, in each case, is selected from C1-10 alkyl substituted with 0-2 Rb, and C1-8 alkyl substituted with 0-2 Re; R8, in each case, is selected from phenyl substituted with 0-2 Rb and biphenyl substituted with 0-2 Rb; R6, in each case, is selected from phenyl, naphthyl, C1-10 alkyl-phenyl-C1-6 alkyl-, C3-11 cycloalkyl, C1-6 alkylcarbonyloxy-C1-3 alkyl-, C1-6 alkoxycarbonyloxy-C1- 3 alkyl-, C2-10 alkoxycarbonyl, C3-6 cycloalkylcarbonyloxy-C1-3 alkyl-, C3-6 cycloalkoxycarbonyloxy-C1-3 alkyl-, C3-6 cycloalkoxycarbonyl, phenoxycarbonyl, phenyloxycarbonyloxy-C1-3 alkyl-, phenylcarbonyloxy-C1- 3 alkyl-, C1-6 C1-6 alkoxy-C1-3 alkylcarbonyloxy-, [5- (C1-5 alkyl) -1,3-dioxa-cyclopenten-2-one-yl] methyl, [5- ( Ra) -1,3-dioxa-cyclopenten-2-one-yl] methyl, (5-aryl-1,3-dioxa-cyclopenten-2-one-yl) methyl, -C1-10 alkyl-NR7R7a, -CH (R8) OC (= O) R9, and CH (R8) OC (= O) OR9; R7 is selected from H and C1-10 alkyl, C2-6 alkenyl, C3-6 cycloalkyl-C1-3 alkyl-, and phenyl-C1-6 alkyl-; R7a is selected from H and C1-10 alkyl, C2-6 alkenyl, C3-6 cycloalkyl-C1-3 alkyl-, and phenyl-C1-6 alkyl-; R8 is selected from H and C1-4 linear alkyl; R9 is selected from H, C1-8 alkyl substituted with 1-2 Rf, C3-8 cycloalkyl substituted with 1-2 Rf, and phenyl substituted with 0-2 Rb; Rf, in each case, is selected from C1-4 alkyl, C3-8 cycloalkyl, C1-5 alkoxy, and phenyl substituted with 0-2 Rb; p, in each case, is selected between 0, 1 and 2; r, in each case, is selected from 0, 1, 2, 3 and 4; and, r1, in each case, is selected from 0, 1, 2, 3, and 4; with the proviso that when none of the pairs R1 and R2, R1 and R3 and R3 and R4a combine to form a ring: (a) XZ-Ua-Xa-Ya-Za forms groups other than those represented by ZO-Za , ZS-Za and ZC (O) -Za, and (b) Ua-Xa-Ya-Za forms distinct groups of an alkoxy group. The pharmaceutical composition comprising these compounds as well as their use in the manufacture of medicaments useful for treating or preventing inflammatory disorders or diseases mediated by MMP, TNF and / or aggrecanase are also described. |
| priorityDate | 2000-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.